Literature DB >> 24603945

Cortical ¹¹C-PIB uptake is associated with age, APOE genotype, and gender in "healthy aging".

Noora M Scheinin1, Kristina Wikman1, Antti Jula2, Markus Perola3, Tero Vahlberg4, Johanna Rokka1, Kjell Någren5, Matti Viitanen6, Juha O Rinne7.   

Abstract

BACKGROUND/
OBJECTIVE: Our aim was to elucidate factors that contribute to amyloid-β (Aβ) accumulation in the brains of the seemingly healthy elderly population, and whether there is interplay between those factors.
METHODS: We conducted a cross-sectional positron emission tomography (PET) study with the amyloid tracer 11C-PIB, in 64 cognitively healthy subjects (54-89 years). In addition to PET, magnetic resonance imaging, neuropsychological testing, and APOE genotyping was performed. The results were assessed with a statistical general linear model as well as with Statistical Parametric Mapping (SPM).
RESULTS: The effects of age (p < 0.001), APOE ε4 carrier status (p = 0.003), and gender (p = 0.001) on composite cortical 11C-PIB uptake were all significant. The effect of educational level was non-significant (p = 0.37). No significant interactions were found between any of the factors. Cortical 11C-PIB uptake increased, on the average, by 0.015 cortex/cerebellar cortical ratio unit, with every year of age. APOE ε4 positive subjects exhibited higher cortical 11C-PIB uptake than APOE ε4 negative subjects (unadjusted means 1.49 ± 0.34 versus 1.29 ± 0.26) and males had higher uptake than females (1.49 ± 0.39 versus 1.29 ± 0.22), irrespective of age. The results of the voxel-based (SPM) analysis were similar. In addition, SPM analysis showed that lower CERAD score was associated with higher 11C-PIB uptake in the frontal cortex.
CONCLUSIONS: Age and APOE ε4 genotype were associated with higher 11C-PIB uptake. In this sample of cognitively healthy elderly individuals, men exhibited higher 11C-PIB uptake than women. Possible gender differences in Aβ accumulation have not been addressed in detail in previous studies, and deeper evaluation in the future is warranted.

Entities:  

Keywords:  APOE; Aging; PET; PIB; amyloid; gender; positron emission tomography

Mesh:

Substances:

Year:  2014        PMID: 24603945     DOI: 10.3233/JAD-132783

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  17 in total

Review 1.  Amyloid deposition in Parkinson's disease and cognitive impairment: a systematic review.

Authors:  Myria Petrou; Ben A Dwamena; Bradley R Foerster; Mark P MacEachern; Nicolaas I Bohnen; Martijn Ltm Müller; Roger L Albin; Kirk A Frey
Journal:  Mov Disord       Date:  2015-04-16       Impact factor: 10.338

Review 2.  Imaging brain effects of APOE4 in cognitively normal individuals across the lifespan.

Authors:  Marine Fouquet; Florent L Besson; Julie Gonneaud; Renaud La Joie; Gaël Chételat
Journal:  Neuropsychol Rev       Date:  2014-08-22       Impact factor: 7.444

Review 3.  Olfactory Identification Deficits, Cognitive Decline, and Dementia in Older Adults.

Authors:  D P Devanand
Journal:  Am J Geriatr Psychiatry       Date:  2016-08-17       Impact factor: 4.105

4.  Longitudinal Amyloid-β PET in Atypical Alzheimer's Disease and Frontotemporal Lobar Degeneration.

Authors:  Jennifer L Whitwell; Nirubol Tosakulwong; Stephen D Weigand; Jonathan Graff-Radford; Joseph R Duffy; Heather M Clark; Mary M Machulda; Hugo Botha; Rene L Utianski; Christopher G Schwarz; Matthew L Senjem; Edythe A Strand; Nilufer Ertekin-Taner; Clifford R Jack; Val J Lowe; Keith A Josephs
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

5.  Gender differences of neuropsychological profiles in cognitively normal older people without amyloid pathology.

Authors:  Jie Zhang; Wenjun Zhou; Lijun Wang; Xiangyang Zhang
Journal:  Compr Psychiatry       Date:  2017-03-01       Impact factor: 3.735

6.  Longitudinal brain imaging in preclinical Alzheimer disease: impact of APOE ε4 genotype.

Authors:  Shruti Mishra; Tyler M Blazey; David M Holtzman; Carlos Cruchaga; Yi Su; John C Morris; Tammie L S Benzinger; Brian A Gordon
Journal:  Brain       Date:  2018-06-01       Impact factor: 13.501

7.  Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community.

Authors:  D P Devanand; Seonjoo Lee; Jennifer Manly; Howard Andrews; Nicole Schupf; Richard L Doty; Yaakov Stern; Laura B Zahodne; Elan D Louis; Richard Mayeux
Journal:  Neurology       Date:  2014-12-03       Impact factor: 9.910

8.  Cerebral cortical Aβ42 and PHF-τ in 325 consecutive brain autopsies stratified by diagnosis, location, and APOE.

Authors:  Nadia Postupna; Christopher Dirk Keene; Paul K Crane; Luis F Gonzalez-Cuyar; Joshua A Sonnen; Jessica Hewitt; Samantha Rice; Kimberly Howard; Kathleen S Montine; Eric B Larson; Thomas J Montine
Journal:  J Neuropathol Exp Neurol       Date:  2015-02       Impact factor: 3.685

9.  Individual estimates of age at detectable amyloid onset for risk factor assessment.

Authors:  Murat Bilgel; Yang An; Yun Zhou; Dean F Wong; Jerry L Prince; Luigi Ferrucci; Susan M Resnick
Journal:  Alzheimers Dement       Date:  2015-11-14       Impact factor: 21.566

10.  The ARIC-PET amyloid imaging study: Brain amyloid differences by age, race, sex, and APOE.

Authors:  Rebecca F Gottesman; Andrea L C Schneider; Yun Zhou; Xueqi Chen; Edward Green; Naresh Gupta; David S Knopman; Akiva Mintz; Arman Rahmim; A Richey Sharrett; Lynne E Wagenknecht; Dean F Wong; Thomas H Mosley
Journal:  Neurology       Date:  2016-07-01       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.